Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Kromek wins US$1.15mln of repeat orders

October was a good month for orders for Kromek, and November has started off well
X-ray
The scanners can detect the early onset of osteoporosis

Kromek Group PLC (LON:KMK) is celebrating repeat orders worth around US$1.15mln for its detector modules from three of its original equipment manufacturer (OEM) customers.

The radiation detection technology company said the orders are from global producers and exporters of bone mineral diagnostic [BMD] systems that incorporate Kromek’s cadmium zinc telluride-based detector modules.

The contracts are expected to be delivered over the next 24 months, with the bulk of the orders expected to be shipped within the next 12 months.

Kromek's detector modules will be incorporated into the OEMs' systems to produce some of the most accurate imaging to diagnose the strength and health of bones, Kromek said.

The CZT-based diagnostic systems will allow clinicians to accurately detect and monitor progression of osteoporosis in patients resulting in more effective treatment.

"It is very pleasing to secure double the orders we received from these long-standing customers last year,” said Dr Arnab Basu, the chief executive officer of Kromek.

“It strengthens our relationship with them and further validates our belief that more and more legacy detection systems are being replaced with BMD diagnostic systems with our CZT detectors. The agreements represent the continued healthy conversion of our pipeline into orders as we continue to win new contracts in the medical sector," he added.

 

John-H.jpg
Why Invest In Kromek Group PLC? Read More Here

Register here to be notified of future KMK Company articles
View full KMK profile View Profile

Kromek Group PLC Timeline

Newswire
February 10 2017

Related Articles

Runner
January 17 2017
The shares ended 2016 at 8.89p having started it at 3.66p. Backers have consistently exercised warrants to acquire more shares.
Brady trading screen
September 12 2016
The shares are up 22% year-to-date despite difficult market conditions
nuclear-hazard.jpg
January 25 2017
The move will allow the company to fully benefit from a step change in the market for detectors, which is adopting CZT technology pioneered by Kromek.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use